Skip to content
Recall Observatory FDA recall evidence

Drug product

Clindamycin Injection, USP, 900 mg/6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA. NDC 47781-621-94

D-1072-2019

March 15, 2019

Class III

Product summary

Firm
Pfizer Inc.
Event
Event 82386
Status
Terminated
Classification
Class III
Quantity
8,320 cartons (25 vials per carton)
Official record key
drug-enforcement:D-1072-2019

Official wording

Reason: Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point

Code information: Lot #: T96398, Exp.07/2019, T97492, Exp.04/2019, W28567, Exp. 09/2019, W31813, Exp.10/2019

Distribution pattern: Nationwide USA and Guam

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out-of-specification